- ¥4bn
- ¥2bn
- ¥2bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,497 | 1,800 | 2,102 | 1,930 | 2,244 |
Cost of Revenue | |||||
Gross Profit | 461 | 525 | 691 | 1,044 | 1,111 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,429 | 1,768 | 1,926 | 1,566 | 1,946 |
Operating Profit | 67.8 | 31.9 | 175 | 364 | 298 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 67.3 | 30.9 | 174 | 349 | 299 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61.1 | 10.6 | 130 | 253 | 230 |
Net Income Before Extraordinary Items | |||||
Net Income | 61.1 | 10.6 | 130 | 253 | 230 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 61.1 | 10.6 | 130 | 253 | 230 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 24.5 | 3.3 | 40.7 | 73.1 | 65.5 |
Dividends per Share |